Intas Biopharma Acquires Biologics Process Development

Intas Biopharmaceuticals Limited (IBPL, Ahmedabad, India) has acquired the US-based biotechnology corporation, Biologics Process Development Incorporated (BPD Inc., Poway, CA). With the acquisition process underway, both companies are actively pursuing plans to work closely toward fulfillment of common business objectives in the area of contract research and manufacturing services (CRAMS). With agreement in the final stages of completion, the financials have been undisclosed and will be announced at a later stage.

The development will facilitate and assist Intas Biopharmaceuticals Limited’s foray in the US market, especially to expand its CRAMS business. Scott M. Brown, PhD, will continue as president and chief scientific officer of BPD Inc., and Rajeev Datar, PhD, will be the new chief executive officer of BPD Inc.